Lynda Coughlan
University of Maryland School of Medicine
9 papers found
Refreshing results…
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Download from www.nature.comPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
UploadMissing publications? Search for publications with a matching author name.